dexmedetomidine
Commercial- Indications
- Schizophrenia, Bipolar disorder
Company intelligence / Profile preview
Bioxell GmbH specializes in high-quality recombinant protein and antibody production services. It has successfully produced over 1500 proteins using five different expression systems and offers both small-scale and large-scale manufacturing capabilities. The company also provides monoclonal/polyclonal antibody development and peptide synthesis services. No clinical results as it does not develop its own therapeutics.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioxell GmbH.